Patents by Inventor Robert Stavis

Robert Stavis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250248628
    Abstract: A system for determining levels or concentrations of a substance in a patient's skin based on an optical property of the substance, including a computing device, a software application stored in a memory of the computing device and configured to run on a processor of the computing device, and a module in communication with the computing device and separated and detached from the computing device, said module including a data communication capability, a status indicator, one or more light, multiple optical pathways that transmit the light from the one or more light sources to two or more areas of the patient's skin, which penetrates the patient's skin to the subcutaneous level and is then reflected and scattered to two or more light sensors that detect the reflected and scattered light originating from the one or more light sources, and a power source.
    Type: Application
    Filed: January 6, 2025
    Publication date: August 7, 2025
    Inventors: Matthew James Clemente, George Stavis, Robert Stavis, Mary Elizabeth Lemma, Steven P. Getz
  • Patent number: 12186051
    Abstract: A system including a computing device, a software application stored in a memory of the computing device and configured to run on a processor of the computing device, and a module in communication with the computing device, said module including a data communication capability, where the data includes light intensity or wavelength information, a light source configured to provide light capable of penetrating the patient's skin to a subcutaneous level, a light sensor configured to detect the light from the light source reflected and scattered from the patient's skin including from the subcutaneous level at a single point in time or sequentially at multiple points in time, and a power source, where the software application is configured to determine levels or concentrations of a substance in a patient's skin based on a measurement of light intensity or wavelength from the light sensor.
    Type: Grant
    Filed: August 26, 2022
    Date of Patent: January 7, 2025
    Assignee: Bilibaby, LLC
    Inventors: Matthew James Clemente, George Stavis, Robert Stavis, Mary Elizabeth Lemma, Steven P. Getz
  • Publication number: 20230069111
    Abstract: A system including a computing device, a software application stored in a memory of the computing device and configured to run on a processor of the computing device, and a module in communication with the computing device, said module including a data communication capability, where the data includes light intensity or wavelength information, a light source configured to provide light capable of penetrating the patient's skin to a subcutaneous level, a light sensor configured to detect the light from the light source reflected and scattered from the patient's skin including from the subcutaneous level at a single point in time or sequentially at multiple points in time, and a power source, where the software application is configured to determine levels or concentrations of a substance in a patient's skin based on a measurement of light intensity or wavelength from the light sensor.
    Type: Application
    Filed: August 26, 2022
    Publication date: March 2, 2023
    Inventors: Matthew James Clemente, George Stavis, Robert Stavis, Mary Elizabeth Lemma, Steven P. Getz
  • Patent number: 9934589
    Abstract: The present invention provides a system and method for determining bilirubin levels in an individual based on skin coloration using a smartphone or other personal device and an attached ancillary apparatus. The device, such as a smartphone or tablet, is capable of storing and running software. The device is also coupled to both a camera and light source to obtain data regarding the skin's coloration. Software is installed on the device to control the light source and calculate bilirubin levels in the individual based on the input received from the camera. The ancillary apparatus is a mechanism surrounding the light source and camera that is placed on the skin of the individual when the system is in use. The ancillary apparatus thus creates a light tight seal between the skin, light source and camera, enabling the system to receive the most accurate data from the camera.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: April 3, 2018
    Assignee: Bilibaby, LLC
    Inventors: Matthew James Clemente, George Stavis, Noureddine Melikechi, Robert Stavis
  • Publication number: 20160012610
    Abstract: The present invention provides a system and method for determining bilirubin levels in an individual based on skin coloration using a smartphone or other personal device and an attached ancillary apparatus. The device, such as a smartphone or tablet, is capable of storing and running software. The device is also coupled to both a camera and light source to obtain data regarding the skin's coloration. Software is installed on the device to control the light source and calculate bilirubin levels in the individual based on the input received from the camera. The ancillary apparatus is a mechanism surrounding the light source and camera that is placed on the skin of the individual when the system is in use. The ancillary apparatus thus creates a light tight seal between the skin, light source and camera, enabling the system to receive the most accurate data from the camera.
    Type: Application
    Filed: April 2, 2015
    Publication date: January 14, 2016
    Inventors: Matthew James Clemente, George Stavis, Noureddine Melikechi, Robert Stavis
  • Publication number: 20030216944
    Abstract: e-mail letters are transmitted to parents or other interested parties in the case of a neonate in a hospital to inform the interested party of the current status based upon data and medical information in the patient's records, utilizing sets of statements which are selected randomly so that each letter differs from previous and succeeding letters and is personalized by the random selection. The method has general business applications as well.
    Type: Application
    Filed: May 16, 2002
    Publication date: November 20, 2003
    Inventor: Robert Stavis